Full Text View  
  Tabular View  
  Contacts and Locations  
  No Study Results Posted  
  Related Studies  
Impact of Treatment Induced Premature Menopause on Quality of Life
This study is currently recruiting participants.
Verified by Stanford University, November 2008
Sponsored by: Stanford University
Information provided by: Stanford University
ClinicalTrials.gov Identifier: NCT00185718
  Purpose

To understand the impact of treatment induced menopause on quality of life and sexuality following blood and marrow transplantation.e.


Condition
Menopause, Premature

MedlinePlus related topics: Bone Marrow Transplantation Menopause
U.S. FDA Resources
Study Type: Observational
Study Design: Prospective
Official Title: Impact of Treatment Induced Premature Menopause on Quality of Life Following Blood and Marrow Transplantation

Further study details as provided by Stanford University:

Estimated Enrollment: 80
Study Start Date: November 2003
  Eligibility

Ages Eligible for Study:   18 Years and older
Genders Eligible for Study:   Female
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:- premenopausal

  • sexually active women
  • able to read and write english
 Exclusion Criteria:- postmenopausal females
  Contacts and Locations
Please refer to this study by its ClinicalTrials.gov identifier: NCT00185718

Contacts
Contact: BMT Referrals (650) 723-0822

Locations
United States, California
Stanford University School of Medicine Recruiting
Stanford, California, United States, 94305
Contact: BMT Referrals     650-723-0822        
Contact: Cancer Clinical Trials Office     (650) 498-7061        
Principal Investigator: Katherine Tierney            
Principal Investigator: Karl G. Blume            
Sponsors and Collaborators
Stanford University
Investigators
Principal Investigator: Karl G. Blume Stanford University
Principal Investigator: Katherine Tierney Stanford University
  More Information

Study ID Numbers: BMT160, 79700, BMT160, NCT00185718
Study First Received: September 12, 2005
Last Updated: November 26, 2008
ClinicalTrials.gov Identifier: NCT00185718  
Health Authority: United States: Food and Drug Administration;   United States: Institutional Review Board

Study placed in the following topic categories:
Genital Diseases, Female
Menopause, Premature
Quality of Life
Ovarian Diseases
Menopause

Additional relevant MeSH terms:
Adnexal Diseases

ClinicalTrials.gov processed this record on January 14, 2009



U.S. National Library of Medicine,  Contact Help Desk
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services